🔥Telegram İfşa

Thrilled that our team has been awarded $2M MRFF grant to trial implementation strategies for lung cancer screening! Joelrhee Billie Bonevski Shalini Vinod Dr Rachael Dodd @markbrooke68 Jon Emery Lillian Leigh GAICD Samantha Quaife Thoracic Oncology Group of Australasia PC4 Sydney Health health.gov.au/ministers/the-…

This week 4 Nov: The 2021 David Danks Oration will be presented by Jon Emery, via Zoom, for his topic: Translating genetic discoveries into primary care practice. Register here: unimelb.zoom.us/webinar/regist…

Landed in Hobart this morning for the first official meeting of PARTNER - a national network connecting clinical trials to rural and regional Australia. More about PARTNER: pursuit.unimelb.edu.au/articles/bring…

Breaking ground on the plan to roll out PARTNER across Australia. Pleased with our progress - especially after lunch @JanRadford @kristi_milley

The PARTNER program will provide regional patients with access to #ClinicalTrials which they might otherwise not be invited into. READ MORE >> pursuit.unimelb.edu.au/articles/bring…

We began developing the CRISP trial ten years ago. The RCT tested a risk-prediction tool for colorectal screening in general practice. In parallel, we conducted an implementation study with practice nurses in a primary care setting. Thanks to PC4 for supporting this study.

In Adelaide today for the annual PC4 Strategic Planning Day. We gave an update on the new MRFF-funded SMARTERscreen trial around increasing #bowel #cancer screening through personalised SMS messages. This builds on the success of the SMARTscreen trial @M_Jefford

Leading the Policy and Advocacy committee for #AAAPC, it’s good to see this comms workshop being run at the conference. Still time to register!

The #AAAPC22 ARC provisional program is jam-packed with plenary presentations, oral presentations, poster walks and interactive workshops designed to inspire and educate. #OurPrimaryCare Program: aaapc.org.au/ARC/program Register to attend: aaapc.org.au/ARC/registrati…

Michael and I shared two of our papers in the Cancer Survivorship The Lancet series on this PC4 podcast episode. Always great to discuss innovative ways to improve cancer survivorship care across the board. Papers: thelancet.com/series/cancer-…

Looking forward to another great edition of the Ca-PRI conference in March. It's been a pleasure to plan #CaPRI2023 with the exec committee.

Jon Emery and @sibel_saya exploring the potential of polygenic risk scores 🧬 to improve early cancer diagnosis through: ⏺️ risk stratified screening and ⏺️ triaging patients with non-specific symptoms #CanTestSummit CanTest PC4 @UMCCR #MagpieTrial

Great discussion around cancer risk prediction and new technologies #CanTestSummit CanTest

Our team has started a Twitter account. Please follow to stay up to date with our newest cancer in primary care research. University of Melbourne Cancer in Primary Care

Are you attending #Surv23 and: ✅interested in primary care research? ✅have a research idea you want some help with? ✅want some free specialist input? ✅need help with applying for funding ✅or do you just want to play researchopoly with us! Come visit us at the PC4 stand!

It’s taken 1️⃣7️⃣ years to implement 14% of evidence-based findings! We need to speed up high quality translational cancer research to impact patient care. University of Melbourne Cancer in Primary Care we are currently running 6 GP clinical trials. Follow us to find out more! Slide by Dr Carolyn Mazariego-Jones #Surv23

Announcing a first in Australia - linking primary care and hospital data for cancer research for the first time. Thank you Mary-Anne Thomas MP Victorian Government for supporting this vital work that will unlock answers to real world questions and improve outcomes. Congrats Jon Emery & team

The CRISP tool increased risk-appropriate screening for bowel cancer in general practice settings, specifically for patients with average risk who were due for screening. It's a promising step towards implementing this tool in practice.